학술논문

Short-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes.
Document Type
journal article
Source
Journal of Clinical Endocrinology & Metabolism; 2014 Feb, Vol. 99 Issue 2, p639-647, 9p
Subject
Language
ISSN
0021972X